Navigation Links
SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
Date:11/12/2008

AUSTIN, Texas, Nov. 12 /PRNewswire/ -- SpineSmith Partners, an innovative bio-medical device company, is collaborating with several senior design teams in The University of Texas Biomedical Engineering Department to help educate students on the design, engineering, and commercialization process of medical devices.

Photo: http://www.ereleases.com/pr/2008-SpineSmith.jpg

The groups of biomedical engineering students will work closely with SpineSmith's product engineers and Ph.D.s to take ideas conceptualized by practicing spine surgeons and design products for commercialization. This design process will educate the students and offer real world experience in the medical device industry.

SpineSmith is researching and developing the cutting edge market of regenerative medicine giving these students an opportunity to be involved with an evolving market. SpineSmith is currently researching and developing different technologies utilizing a patient's own adult stem cells for tissue regeneration in orthopedics and the spine. With more than 10,000 stem cell cases to date, SpineSmith can revolutionize the regenerative medicine market and give these students an opportunity to make an impact in the product development process.

The mission of the Department of Biomedical Engineering at The University of Texas is to develop clinically translatable solutions for human health by training the next generation of biomedical engineers, cultivating leaders, and nurturing the integration of science, engineering, and medicine in a discover-centered environment.

"SpineSmith believes in the future of regenerative medicine and through this partnership we can utilize the distinguished students at The University of Texas to collaborate in the research and development of products that will impact patients throughout the world," Steve Melchiode, president of SpineSmith, said.

SpineSmith believes collaborating with one of the nation's largest research centers gives SpineSmith a competitive advantage to the numerous companies trying to enter the regenerative medicine market. The opportunity to work with the distinguished students of The University of Texas gives SpineSmith a wealth of knowledge and a source for job candidates who will be the future of the medical device marketplace.

About SpineSmith Partners, LP

(Logo: http://www.ereleases.com/pr/SpineSmith-logo.jpg )

SpineSmith Partners, LP designs, develops and markets implants and biologics for surgical fixation, correction and tissue regeneration of the spine. The company focuses on development of truly innovative biological and hardware technologies for use in the treatment of patients with spinal disorders. Fusionary(TM) is a product by SpineSmith, an Austin, Texas-based company. For more information, visit http://www.spinesmithusa.com or call 512.206.0770.

About UT, Austin

The University of Texas Department of Biomedical Engineering is a joint venture among The University of Texas at Austin, The University of Texas M.D. Anderson Cancer Center and the University of Texas Health Science Center at Houston. The multi-institutional effort combines the strength of one of the nation's largest research universities, the nation's top cancer research center, and a premier medical school.

Media Contacts:

Keri Kimler, SpineSmith, (512) 206-0770

Prof. James Tunnell, UT, Austin, (512) 232-2110

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE SpineSmith Partners, LP
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
2. Medical Simulation Corporation Announces Partnership With University of South Florida
3. Health Robotics Announces Strategic Partnership in Japan for its CytoCare(TM) Robot with TOSHO Inc.
4. AmeriCares Presents Power of Partnership Award to Baxter
5. Global Med Technologies(R), Inc. Partners With Biomedical Synergies to Offer Advanced Tissue Tracking Solutions for Hospitals and Surgery Centers
6. PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress
7. PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
8. Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference
9. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
10. Diagenic Partners With DNAVision to Offer First Breast Cancer and Alzheimers Gene-Expression Blood Tests
11. DuPont and State of Delaware Unveil $80 Million Innovation Center Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)...   Sienna Biopharmaceuticals, Inc. , a privately held, ... Richard Peterson will join the company as ... who brings more than two decades of global financial ... retiring at the end of April but will continue ... Sienna from Novan, Inc., where he served as Chief ...
(Date:3/23/2017)... ... 2017 , ... AxioMed president, Jake Lubinski, describes the AxioMed ... deformed, which is identical to how the human discs work to distribute force. ... to its natural state along a hysteresis curve, exactly like a healthy human ...
(Date:3/23/2017)... DUBLIN , Mar 23, 2017 ... "Biorefinery Products: Global Markets" report to their offering. ... The ... from $466.6 Billion in 2016 at a CAGR of 8.9%, ... of energetic and non-energetic bioproducts into seven major product segments: ...
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
Breaking Biology Technology:
(Date:3/6/2017)... 6, 2017 Mintigo , the ... announced Predictive Sales Coach TM , its new ... intelligence into Salesforce. This unique AI application will ... organizations with deep knowledge of their customers and ... engagement. Predictive Sales Coach extends Mintigo,s existing customer ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
(Date:2/28/2017)...  EyeLock LLC, ein marktführendes Unternehmen im Bereich ... Lösung zur Iris-Erkennung auf der neuesten Mobilplattform ... dem Mobile World Congress 2017 (27. Februar ... 3, Stand 3E10, vorstellen. Der ... – eine Kombination aus Hardware, Software und ...
Breaking Biology News(10 mins):